ASX Announcements

30 July 2021

Appendix 4C

LCT continues to conserve cash, ending the quarter with a cash balance of $1,568,928 compared to $2,240,007 in the previous quarter.

Net operating cash flow in the quarter was ($671,062) compared to ($188,893) in the previous quarter. Receipts from grants and tax incentives were $84,644, lower than the previous quarter of $186,901.


19 July 2021

Appendix 3Z

15 July 2021

LCT appoints interim CEO

The Board of Living Cell Technologies Limited has appointed Chair Professor Bernie Tuch as Interim CEO on terms to be finalised. He will assume the additional role following the retirement of Dr Ken Taylor on Friday 16 July 2021.

Dr Taylor’s retirement means he will also retire from the Board of LCT. He joined LCT as CEO in February 20...

4 July 2021

Notice of cessation of securities

4 July 2021

Appendix 3Y